biobuild

What biobuild does

BioBuild is a Baltimore, Maryland-based private company that provides zero-code bioinformatics software for building and analyzing genomic data workflows. The firm's stated value proposition is to make bioinformatics accessible to non-programmers by eliminating the coding expertise typically required to construct genomic pipelines, thereby enabling researchers and life sciences professionals to perform bioinformatics analysis without writing code. BioBuild operates on a for-profit basis with a headcount of 11-50 employees and maintains a web presence at biobuild.bio under the tagline "Bioinformatics, without the code."

The company's product surface, as evidenced in the source data, is a no-code platform aimed at researchers and life sciences professionals who are blocked from conventional bioinformatics tooling by programming prerequisites. Its differentiator is workflow accessibility rather than underlying algorithmic novelty: the source material does not disclose proprietary models, named pipeline components, integration partners, certifications, or platform architecture details. No specific products, modules, or feature catalog are named in the available evidence, and no API or SDK offering is disclosed. Customer segments, customer logos, partnerships, awards, and patents are all absent from the source data.

Business model mechanics are not disclosed. There is no public pricing model, no publicly stated revenue model, no disclosed funding history, no management team information, and no parent company or subsidiary structure. Source data explicitly states pricing is not publicly disclosed. As a result, the company's monetization approach, contract structure, GTM motion, and capital position are unverified, and the commercial maturity of BioBuild cannot be assessed from the available evidence beyond its self-described positioning.

Name

biobuild

Website

https://biobuild.bio

Company type

Private

Headcount range

11–50 employees

Short description

BioBuild is a Baltimore-based private company that provides zero-code bioinformatics software, enabling researchers and life sciences professionals to build and analyze genomic data workflows without programming expertise. The firm employs 11-50 people.

Ownership category

akta.pro rank

Headquarters

HQ city

Baltimore

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations

Core offering

BioBuild provides zero-code bioinformatics software for building and analyzing genomic data workflows. The platform is designed to make bioinformatics accessible to researchers and life sciences professionals by eliminating the need for coding expertise. The company's tagline positions the product as "Bioinformatics, without the code."

Product overview

Based on the source data, no specific products or services are named or described. The company tagline is "BioBuild: Bioinformatics, without the code," suggesting a no-code bioinformatics solution, but no individual products, modules, or platform architecture details are provided in the available source.

Differentiator

Problem solved

Functional benefit

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves1 record

Direct peers

• DNAnexus: DNAnexus is a cloud platform for storing, processing, and analyzing genomic data. Its genomic analysis infrastructure and research users closely overlap with BioBuild's building and analysis use case.
• Genedata: Genedata provides enterprise software for biopharma R&D, including omics data management and analysis workflows. It overlaps with BioBuild's life-science informatics focus but typically serves larger, more established R&D organizations.
• DNASTAR: DNASTAR offers molecular-biology and sequence-analysis software through its Lasergene product line. It is comparable to BioBuild in providing computational analysis tools to researchers, while serving a more established desktop-oriented workflow.
• Seven Bridges: Seven Bridges provides genomic data analysis and workflow software for biomedical research organizations. It is a direct comparator in genomic workflow execution, analysis, and research-team deployment.
• Partek: Partek develops software for genomic data analysis, visualization, and workflow management. Its genomic-analysis workflow offering and life-science research customers make it a direct peer.
• Benchling: Benchling provides cloud software for biotech R&D, including molecular-biology data management, collaboration, and bioinformatics workflows. It is directly comparable to BioBuild's life-science workflow software and overlapping researcher customer base.
• Geneious: Geneious provides desktop and cloud software for DNA and protein analysis, sequence workflows, and molecular-biology research. It is directly comparable to BioBuild's focus on accessible bioinformatics analysis, although its product is more established and sequence-analysis oriented.
• Rosalind: Rosalind is a cloud bioinformatics and collaboration platform designed for biologists and life-science teams. It is directly comparable to BioBuild's goal of making genomic analysis more accessible to non-programmers.

Broad incumbents

• Dassault Systèmes BIOVIA: Dassault Systèmes BIOVIA provides a broad life-science R&D software suite covering scientific data management, analysis, and research workflows. It is a broad incumbent adjacent to BioBuild's bioinformatics workflow offering, with a wider enterprise platform scope.
• QIAGEN: QIAGEN offers established molecular-testing and life-science products, including the CLC Genomics Workbench and Digital Insights bioinformatics portfolio. It is a broad incumbent with substantial overlap in genomic analysis software and life-science customers.

Market position

Strengths3 records

Competitive moat1 record

Key risks5 records

Key highlights4 records

Customer concentration

• LinkedInlinkedin.com/company/omicsbuild

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about biobuild